Inventor · disambiguated record
Sean B. Carroll
Also filed as: CARROLL SEAN · CARROLL SEAN B
19 granted patents·6 pending applications·657 citations·filing 1989–2023
96Inventor score
Top patents by PatentIndex Score
25 records- 0195US5196193AAntivenoms and methods for making antivenomsOPHIDIAN PHARM INC·Filed 1989·Granted Mar 23, 1993·128 cites·31 claims
- 0294US10682325B2Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wastingAXCELLA HEALTH INC·Filed 2018·Granted Jun 16, 2020·8 cites·42 claims
- 0393US10660870B2Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wastingAXCELLA HEALTH INC·Filed 2019·Granted May 26, 2020·7 cites·28 claims
- 0489US5601823AAvian antitoxins to clostridium difficle toxin AOPHIDIAN PHARM INC·Filed 1993·Granted Feb 11, 1997·81 cites·15 claims
- 0584US5545721AConjugates for the prevention and treatment of sepsisOPHIDIAN PHARM INC·Filed 1993·Granted Aug 13, 1996·72 cites·30 claims
- 0683US11571404B2Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wastingAXCELLA HEALTH INC·Filed 2020·Granted Feb 7, 2023·1 cites·25 claims
- 0782US5443976AImmobilization of Crotalus atrox and Crotalus durissus terrificus whole venoms on aldehyde-activated agaroseOPHIDIAN PHARM INC·Filed 1994·Granted Aug 22, 1995·38 cites·1 claims
- 0880US5762934AClostridium difficile toxin disease therapyOPHIDIAN PHARM INC·Filed 1995·Granted Jun 9, 1998·45 cites·16 claims
- 0979US5719267AClostridial toxin disease therapyOPHIDIAN PHARM INC·Filed 1995·Granted Feb 17, 1998·44 cites·10 claims
- 1075US5599539ATherapy for clostridial botulinum toxinOPHIDIAN PHARM INC·Filed 1994·Granted Feb 4, 1997·50 cites·10 claims
- 1174US11058654B2Compositions and methods for the treatment of hemoglobinopathies and thalassemiasAXCELLA HEALTH INC·Filed 2019·Granted Jul 13, 2021·1 cites·14 claims
- 1274US5904922ATreatment with polyvalent antivenom containing immunoglobulin which is greater than 50% venom-reactiveOPHIDIAN PHARM INC·Filed 1995·Granted May 18, 1999·33 cites·12 claims
- 1374US5814477ARecombinant clostridial toxin proteinOPHIDIAN PHARM INC·Filed 1995·Granted Sep 29, 1998·33 cites·5 claims
- 1473US6660267B1Prevention and treatment of sepsisPROMEGA CORP·Filed 1994·Granted Dec 9, 2003·30 cites·32 claims
- 1572US5605691AImmunologically active proteins from inclusion bodiesOPHIDIAN PHARM INC·Filed 1993·Granted Feb 25, 1997·41 cites·13 claims
- 1669US6656468B1Clostridial toxin disease therapyPROMEGA CORP·Filed 1997·Granted Dec 2, 2003·26 cites·15 claims
- 1768US2024190923A1Broad spectrum metalloproteinase inhibitor for the treatment of snakebiteUNIV MARYLAND·Filed 2023·Application pending·0 cites
- 1863US2021290574A1Compositions and methods for the treatment of hemoglobinopathies and thalassemiasAXCELLA HEALTH INC·Filed 2021·Application pending·0 cites
- 1961US5340923AMethods for making and purifying antivenomsOPHIDIAN PHARM INC·Filed 1992·Granted Aug 23, 1994·15 cites·5 claims
- 2061US2004062771A1Clostridial toxin disease therapyPROMEGA CORP·Filed 2003·Application pending·0 cites
- 2157US2019046486A1Compositions and methods for the treatment of neuronal injuryAXCELLA HEALTH INC·Filed 2018·Application pending·0 cites
- 2254US11617731B2Amino acid compositions and their use for the treatment of traumatic brain injuryAXCELLA HEALTH INC·Filed 2018·Granted Apr 4, 2023·0 cites·8 claims
- 2346US2023105984A1Compositions and methods for the treatment of liver diseases and disordersDAOU NADINE·Filed 2020·Application pending·0 cites
- 2442US2023000808A1Compositions and methods excluding or with reduced glutamine for the treatment of hemoglobinopathies and thalassemiasWANI REVATI·Filed 2020·Application pending·0 cites
- 2535US6613326B1Antitoxins and methods for making antitoxinsPROMEGA CORP·Filed 1994·Granted Sep 2, 2003·4 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Sean B. Carroll files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →